523 related articles for article (PubMed ID: 15067541)
21. Immunotherapy in nonmelanoma skin cancer.
Ghafouri-Fard S; Ghafouri-Fard S
Immunotherapy; 2012 May; 4(5):499-510. PubMed ID: 22642333
[TBL] [Abstract][Full Text] [Related]
22. Considerations on clinical use of T cell immunotherapy for cancer.
Plautz GE; Cohen PA; Shu S
Arch Immunol Ther Exp (Warsz); 2003; 51(4):245-57. PubMed ID: 12956434
[TBL] [Abstract][Full Text] [Related]
23. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
24. Cellular and vaccine immunotherapy for multiple myeloma.
Garfall AL; Stadtmauer EA
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):521-527. PubMed ID: 27913524
[TBL] [Abstract][Full Text] [Related]
25. Role of Immune Therapies for Myeloma.
Rosenblatt J; Avigan D
J Natl Compr Canc Netw; 2015 Nov; 13(11):1440-7. PubMed ID: 26553769
[TBL] [Abstract][Full Text] [Related]
26. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
27. Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?
Zöller M
Technol Cancer Res Treat; 2003 Jun; 2(3):237-60. PubMed ID: 12779354
[TBL] [Abstract][Full Text] [Related]
28. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
29. [Current possibilities in immunotherapy of cancer].
von Fliedner V
Schweiz Med Wochenschr; 1987 Feb; 117(7):243-8. PubMed ID: 3551061
[TBL] [Abstract][Full Text] [Related]
30. [Present status in studying immunotherapy for acute leukemia and its perspective--Editorial].
Wang ZY; Chen QS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):169-73. PubMed ID: 15854271
[TBL] [Abstract][Full Text] [Related]
31. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation.
Slavin S; Morecki S; Weiss L; Or R
J Hematother Stem Cell Res; 2002 Apr; 11(2):265-76. PubMed ID: 11983098
[TBL] [Abstract][Full Text] [Related]
32. The promise of T-lymphocyte immunotherapy for the treatment of malignant disease.
Thomas AK; June CH
Cancer J; 2001; 7 Suppl 2():S67-75. PubMed ID: 11777267
[TBL] [Abstract][Full Text] [Related]
33. Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.
Sinkovics JG
Acta Microbiol Immunol Hung; 2010 Dec; 57(4):253-347. PubMed ID: 21183421
[TBL] [Abstract][Full Text] [Related]
34. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines.
Lohmueller J; Finn OJ
Pharmacol Ther; 2017 Oct; 178():31-47. PubMed ID: 28322974
[TBL] [Abstract][Full Text] [Related]
35. Landscape of Tumor Antigens in T Cell Immunotherapy.
Ilyas S; Yang JC
J Immunol; 2015 Dec; 195(11):5117-22. PubMed ID: 26589749
[TBL] [Abstract][Full Text] [Related]
36. Role of Clinical Pharmacology in the Development and Approval of Immunotherapies Targeting Immune Checkpoints.
Rahman A
Clin Pharmacol Ther; 2016 Dec; 100(6):591-593. PubMed ID: 27500894
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
[TBL] [Abstract][Full Text] [Related]
38. Cancer immunotherapy: accomplishments to date and future promise.
Helmy KY; Patel SA; Nahas GR; Rameshwar P
Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
[TBL] [Abstract][Full Text] [Related]
39. Immune approaches to the treatment of breast cancer, around the corner?
Criscitiello C; Esposito A; Gelao L; Fumagalli L; Locatelli M; Minchella I; Adamoli L; Goldhirsch A; Curigliano G
Breast Cancer Res; 2014 Feb; 16(1):204. PubMed ID: 25774617
[TBL] [Abstract][Full Text] [Related]
40. Immunotherapy: on the edge between experimental and clinical oncology.
Fagnoni FF; Robustelli della Cuna G
J Chemother; 2001 Feb; 13(1):15-23. PubMed ID: 11233795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
